Cancer models developed with 3D bioprinting technology allow for rapid evaluation of individual drug responses.

Understanding the behavior of tiny droplets in our cells could aid the search for new treatments. A team of Leiden ...

A temporally resolved CRISPR-Cas9 screen reveals DAC-induced DNA damage drives trans-cell cycle cytotoxicity that depends on ...

A new version of Cellpose —the popular tool that maps the boundaries of diverse cells in microscopy images —now works on less-than-perfect pictures that are noisy, blurry, or undersampled.

NEW YORK - IN8bio, Inc. (NASDAQ:INAB), a biopharmaceutical company specializing in gamma-delta T cell therapies, reported ...

4, 2025 — Research has shown that a potential new targeted therapy for childhood brain cancer is effective in infiltrating and killing tumor cells ... of acute myeloid leukemia and ...

Jan. 14, 2025 — A team of researchers has developed a new biomaterial with high potential in in the treatment of bone lesions or minimal residual disease in multiple myeloma patients. The ...

Megakaryocytes form a three-dimensional (3D) cage composed of laminin and collagen IV connected to the basement membrane surrounding them. This microarchitecture stabilizes megakaryocytes within their ...

The genetics behind the progression of myelodysplasia to secondary acute myeloid leukemia (sAML ... and splicing machinery were found in T-cell samples, which expand at the initial diagnosis ...

HOUSTON - Moleculin Biotech, Inc. (NASDAQ:MBRX), a late-stage pharmaceutical company currently trading near its 52-week low of $0.66, announced it has received the first European regulatory approval ...